anpac_logo_full color_stacked.png
AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of American Depositary Shares
November 09, 2021 23:55 ET | Anpac Bio, USA
PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC, the “Company”), a biotechnology company with operations in China and the United States focusing on...
anpac_logo_full color_stacked.png
UPDATE - AnPac Bio Commences Proposed Public Offering of American Depositary Shares
November 09, 2021 17:21 ET | Anpac Bio, USA
PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC, the “Company”), a biotechnology company with operations in China and the United States focusing on...
anpac_logo_full color_stacked.png
AnPac Bio Commences Proposed Public Offering of American Depositary Shares
November 09, 2021 16:59 ET | Anpac Bio, USA
SUNRISE, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC, the “Company”), a biotechnology company with operations in China and the United States focusing on...
biomerica.png
Biomerica Launches New Website for Its Aware® Breast Exam Device
October 29, 2021 08:19 ET | Biomerica, Inc.
Simple at-home breast exam device provides results within minutesStudies show increase in Breast Exam Sensitivity IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA)...
biomerica.png
Walmart to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Screening Test
October 19, 2021 06:39 ET | Biomerica, Inc.
Over 4,600 Walmart Stores to sell the EZ Detect™ productSimple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) --...
anpac_logo_full color_stacked.png
AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases
October 04, 2021 07:30 ET | Anpac Bio, USA
PHILADELPHIA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq:ANPC, “AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United...
anpac_logo_full color_stacked.png
AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3%
October 01, 2021 07:30 ET | Anpac Bio, USA
PHILADELPHIA, Oct. 01, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
anpac_logo_full color_stacked.png
AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities Deficiency
September 30, 2021 16:05 ET | Anpac Bio, USA
PHILADELPHIA, Sept. 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States...
anpac_logo_full color_stacked.png
AnPac Bio Increases Ownership Percentage of its Subsidiary AnPai Healthcare from 20% to 60%
September 03, 2021 16:15 ET | Anpac Bio, USA
PHILADELPHIA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States...
anpac_logo_full color_stacked.png
AnPac Bio’s USA Laboratory Receives Accreditation from the College of American Pathologists
August 30, 2021 07:30 ET | Anpac Bio, USA
PHILADELPHIA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States...